# Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase

> **NCT07550296** · PHASE2 · NOT_YET_RECRUITING · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 122 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** prourokinase

## Key facts

- **NCT ID:** NCT07550296
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550296, "Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07550296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*